Pulsatile gonadotropin-releasing hormone therapy of anovulatory infertility.
A new treatment of anovulatory infertility has been introduced during the last few years. Pulsatile long-term administration of the hypothalamic gonadotropin-releasing hormone by means of small portable computerized infusion pumps has proved to be a safe, effective and acceptable out-patient treatment of infertility due to inadequate gonadotropin secretion. In the future, the practical pulsatile LRH treatment will in all probability to a great extent replace the present more laborious human gonadotropin therapy of anovulatory infertility.
D000858:Anovulation / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D007248:Infertility, Male / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D013091:Spermatogenesis / Q000187:drug effects
D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone